Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA issues complete response to BioDelivery's Onsolis NDA

Aug. 29, 2008

Novel antiinflammatory TRPV1 antagonists identified at Johnson & Johnson

Aug. 29, 2008

COX-2 inhibitor NS-398 modulates effects of nitroglycerin-induced migraine in rats

Aug. 29, 2008

Souvenaid improves memory in mild Alzheimer's disease patients

Aug. 29, 2008

Pardoprunox meets safety and efficacy endpoints in phase II Parkinson's disease studies

Aug. 29, 2008

Pain Therapeutics and King Pharmaceuticals develop a new abuse-resistant pain medication

Aug. 28, 2008

FDA reports two new cases of PML in patients receiving Tysabri as monotherapy for MS

Aug. 28, 2008

Novel therapeutic agents for neurological disorders divulged in recent patents

Aug. 28, 2008

Effects of LY-450139 on Abeta studied with novel labeling agent 13C6-leucine

Aug. 28, 2008

Studies reveal neurological effects of berberine

Aug. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...